Synapse - Maria Arcila

Results (670)

Export to EndNote / Excel | PubMed

ERBB2 (HER2) gene amplification and protein overexpression in ampullary carcinoma

Meeting Abstract

Hechtman, J.; Arcila, M.; Vakiani, E.; Shia, J. R.; Klimstra, D.
Laboratory Investigation (2015)

Fulltext@MSK | Save

ERBB2 (HER2) gene amplification and protein overexpression in ampullary carcinoma

Meeting Abstract

Hechtman, J.; Arcila, M.; Vakiani, E.; Shia, J. R.; Klimstra, D.
Modern Pathology (2015)

Fulltext@MSK | Save

Comprehensive assessment of targetable driver alterations in lung adenocarcinomas using a clinical, hybrid capture-based, next-generation sequencing assay

Meeting Abstract

Arcila, M.; Zehir, A.; Cheng, D.; Yu, H.; Kris, M.; Drilon, A.; Riely, G.; Berger, M.; Ladanyi, M.
Modern Pathology (2015)

Fulltext@MSK | Save

Comprehensive assessment of targetable driver alterations in lung adenocarcinomas using a clinical, hybrid capture-based, next-generation sequencing assay

Meeting Abstract

Arcila, M.; Zehir, A.; Cheng, D.; Yu, H.; Kris, M.; Drilon, A.; Riely, G.; Berger, M.; Ladanyi, M.
Laboratory Investigation (2015)

Fulltext@MSK | Save

Prospective blinded study of BRAFV600E mutation detection in cell-free DNA of patients with systemic histiocytic disorders

Journal Article

Hyman, D. M.; Diamond, E. L.; Vibat, C. R. T.; Hassaine, L.; Poole, J. C.; Patel, M.; Holley, V. R.; Cabrilo, G.; Lu, T. T.; Arcila, M. E.; more...
Cancer Discovery (2015)

Fulltext@MSK | Save

Alterations in two oncogenic drivers: Impact of concurrent PIK3CA or AKT1 mutations in patients with oncogene-driven lung adenocarcinomas

Meeting Abstract

Eng, J.; Hellmann, M. D.; Woo, K.; Sima, C. S.; Yu, H. A.; Arcila, M. E.; Ladanyi, M.; Kris, M. G.; Drilon, A. E.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Next-generation sequencing (NGS) to identify actionable genomic alterations (GA) in "pan-negative" lung adenocarcinomas (ADC) from patients with no smoking or a light smoking (NS/LS) history

Meeting Abstract

Drilon, A. E.; Wang, L.; Arcila, M. E.; Cho, E. J.; Balasubramanian, S.; Greenbowe, J. R.; Ross, J. S.; Stephens, P.; Lipson, D.; Miller, V. A.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Clinical and in vivo evidence that EGFR S768I mutant lung adenocarcinomas are sensitive to erlotinib

Journal Article

Hellmann, M. D.; Reva, B.; Yu, H.; Rusch, V. W.; Rizvi, N. A.; Kris, M. G.; Arcila, M. E.
Journal of Thoracic Oncology (2014)

Fulltext@MSK | Save

A comprehensive clinical next generation sequencing-based assay can impact hematopathologic diagnosis in a significant subset of patients with hematologic malignancies